AUTISM DISORDER TREATMENT MARKET ANALYSIS

Leading Companies

Competitive Analysis

Key players operating in the global autism disorder treatment market include Janssen Pharmaceuticals, Inc., Actavis, Inc., Curemark LLC, Pediatric Bioscience, Inc., Novartis AG, Teva Pharmaceuticals Industries Ltd, Mylan NV, Pfizer, Inc., Bristol Myers Squibb, Par Sterile Products LLC, F. Hoffman La Roche, and others. Major players are focusing on extensive research and development to receive product approvals from the FDA and introducing new drugs to the market. For instance, in January 2018, Switzerland-based drug maker, Roche, received U.S. FDA grant for its breakthrough therapy, Balovaptan, for treatment of autism spectrum disorder.